Searched for
IRINOTECAN
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- Venus Remedies gets new market authorisations for drugs in VietnamPharma major Venus Remedies has received new marketing authorisations in Vietnam for its drugs Methotrexate, Cefuroxime, and Irinotecan. Th...
- GST Rate Changes 2025: Check full list of items with revised rates effective from Navratri, September 22GST Rates List 2025: The GST Council has announced tax slab revisions impacting almost all goods and services. After the rationalisation of...
- These large- and mid-cap stocks can give more than 28 % return in 1 year, according to analystsThe way the market reacted to the GST rate rationalisation clearly shows that “sell-on-news mode” is still active. Now there are two reason...
- Wealth creation is the gap between noise & compounding: 6 mid-caps from different sectors with upside potential of up to 36%As tariffs and GST rationalisation jostle for the attention of the street, the market is trying to translate every nuance into price. The l...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAre valuations in the mid-cap segment now fairly priced? No. Does it mean you should avoid the segment altogether? The answer is again no. ...
- This time tailwinds for good and long term: 5 midcap pharma stocks where probably management has learnt the lessonPharma is one sector, where literally every company in the sector has gone through a phase where it is forced to have a look at its own bus...
- Venus Remedies gets marketing authorisations for three cancer drugs from UkraineSaransh Chaudhary, President, Global Critical Care, Venus Remedies, said, "These marketing approvals mark a significant milestone in our gl...
- On a path to recovery: 4 small pharma stocks with an upside potential of up to 27%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are small and mi...
- Essential medicines list: Govt adds 34 new drugs, drops 26; all you need to knowSeveral anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List...
- IIT Madras researchers identify a sustainable, high-yielding alternative source for anti-cancer drug CamptothecinThe researchers have found a way to produce the drug using a novel microbial fermentation method that produces high yield without too much ...
- Shilpa Medicare gets USFDA nod for cancer treatment injectionShares of Shilpa Medicare were trading 3.80 per cent up at Rs 398.65 apiece on BSE.
- 'Combo therapy against ovarian, breast cancer can overcome drug resistance'Kolkata, Sep 26 (IANS) Bolstering the knowhow behind targeted cancer treatment, Indian scientists have offered a new rationale for combinat...
- NPPA invites comments on Tata Memorial list of cancer drugs"(this is) on revision of NLEM 2011 with respect to addition/ deletion of drugs relating to oncology from price control and affordability a...
- Eli Lilly enters branded generics; launches four cancer drugsDrug firm Eli Lilly and Company India today said it has entered into branded generics segment in the country with the launch of four cancer...
- Venus receives nod for four plants from Australian authorityVenus Remedies has received approval from Australian authorities for 4 of its facilities, thus enabling the company to export products from...
- German firm Fresenius leads race for Dabur PharmaSources say that Fresenius Kabi is in advanced talks with the Indian company and has valued Dabur Pharma at over Rs 1,000 cr. Corporate Ind...
- Dabur Pharma launches cancer treating injection in USDabur Pharma on Friday announced the approval and launch of Irinotecan Hydrochloride Injection in the US, used mainly in treating rectum ca...
- Dabur Pharma gets approval for Irinotecan injectionDabur Pharma has received approval for the launch of Irinotecan hydrochloride injection in US.
- Dabur Pharma forays into Pak anti-cancer drug mktStepping up its overseas expansion, Dabur Pharma has made a foray into the anti-cancer drug market in Pakistan and Turkmenistan.
Load More
